El-Tahan R, Oriquat G, Sorour I, Salem S, Kamel M, Michel T
Sci Rep. 2024; 14(1):27779.
PMID: 39537688
PMC: 11561067.
DOI: 10.1038/s41598-024-77643-9.
Minaei Noshahr R, Amouzadeh Omrani F, Yadollahzadeh Chari A, Salehpour Roudsari M, Madadi F, Shakeri Jousheghan S
Arch Bone Jt Surg. 2024; 12(9):612-621.
PMID: 39498221
PMC: 11531769.
DOI: 10.22038/ABJS.2024.70918.3319.
Huang H, Chen J, Lin X, Lin Z
Calcif Tissue Int. 2024; 115(5):673-685.
PMID: 39198270
PMC: 11531433.
DOI: 10.1007/s00223-024-01271-8.
Zhang L, Zhang C, Zheng J, Wang Y, Wei X, Yang Y
Stem Cell Rev Rep. 2023; 20(2):554-567.
PMID: 38150082
PMC: 10837250.
DOI: 10.1007/s12015-023-10666-3.
Jiao Y, Mi S, Li X, Liu Y, Han N, Xu J
BMC Oral Health. 2023; 23(1):955.
PMID: 38041017
PMC: 10693016.
DOI: 10.1186/s12903-023-03443-8.
Cabozantinib and IL-27 combinatorial therapy for bone-metastatic prostate cancer.
Kumar S, Mulia G, Figueiredo M
Front Mol Biosci. 2023; 10:1259336.
PMID: 37842640
PMC: 10568464.
DOI: 10.3389/fmolb.2023.1259336.
MicroRNAs and Periodontal Disease: Helpful Therapeutic Targets?.
Palideh A, Vaghari-Tabari M, Nosrati Andevari A, Qujeq D, Asemi Z, Alemi F
Adv Pharm Bull. 2023; 13(3):423-434.
PMID: 37646047
PMC: 10460817.
DOI: 10.34172/apb.2023.048.
MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease.
Smout D, Van Craenenbroeck A, Jorgensen H, Evenepoel P
Clin Kidney J. 2023; 16(3):408-421.
PMID: 36865016
PMC: 9972833.
DOI: 10.1093/ckj/sfac219.
Cellular and Molecular Mechanisms Associating Obesity to Bone Loss.
Forte Y, Renovato-Martins M, Barja-Fidalgo C
Cells. 2023; 12(4).
PMID: 36831188
PMC: 9954309.
DOI: 10.3390/cells12040521.
Role of miRNA-155 in the regulation of osteoclast differentiation mediated by MITF in stage III/IV periodontitis: a case-control study.
Nandipati S, Appukuttan D, Subramanian S, Prakash P
J Genet Eng Biotechnol. 2022; 20(1):161.
PMID: 36459254
PMC: 9718899.
DOI: 10.1186/s43141-022-00441-1.
Interaction Between Non-Coding RNAs and Interferons: With an Especial Focus on Type I Interferons.
Ghafouri-Fard S, Poornajaf Y, Dashti F, Hussen B, Taheri M, Jamali E
Front Immunol. 2022; 13:877243.
PMID: 35572537
PMC: 9091820.
DOI: 10.3389/fimmu.2022.877243.
Connection between Mesenchymal Stem Cells Therapy and Osteoclasts in Osteoarthritis.
Ibanez L, Guillem-Llobat P, Marin M, Guillen M
Int J Mol Sci. 2022; 23(9).
PMID: 35563083
PMC: 9102843.
DOI: 10.3390/ijms23094693.
Regulation of osteoclast-mediated bone resorption by microRNA.
Ji L, Li X, He S, Chen S
Cell Mol Life Sci. 2022; 79(6):287.
PMID: 35536437
PMC: 11071904.
DOI: 10.1007/s00018-022-04298-y.
Role of Exosomal Non-Coding RNAs in Bone-Related Diseases.
Li H, Zheng Q, Xie X, Wang J, Zhu H, Hu H
Front Cell Dev Biol. 2022; 9:811666.
PMID: 35004702
PMC: 8733689.
DOI: 10.3389/fcell.2021.811666.
Association of MIR17HG and MIR155HG gene variants with steroid-induced osteonecrosis of the femoral head in the population of northern China.
Liu T, Cao Y, Han C, An F, Wang T, Sun M
J Orthop Surg Res. 2021; 16(1):673.
PMID: 34781979
PMC: 8594148.
DOI: 10.1186/s13018-021-02669-y.
B7-H3 regulates osteoclast differentiation via type I interferon-dependent IDO induction.
Oh Y, Park R, Kim S, Park S, Jo S, Kim T
Cell Death Dis. 2021; 12(11):971.
PMID: 34671026
PMC: 8528854.
DOI: 10.1038/s41419-021-04275-6.
MicroRNA-151a-3p Functions in the Regulation of Osteoclast Differentiation: Significance to Postmenopausal Osteoporosis.
He Y, Chen D, Guo Q, Shi P, You C, Feng Y
Clin Interv Aging. 2021; 16:1357-1366.
PMID: 34290498
PMC: 8286966.
DOI: 10.2147/CIA.S289613.
Regulation of Osteoclastogenesis and Bone Resorption by miRNAs.
Inoue K, Ng C, Xia Y, Zhao B
Front Cell Dev Biol. 2021; 9:651161.
PMID: 34222229
PMC: 8249944.
DOI: 10.3389/fcell.2021.651161.
Effects of fluid flow shear stress to mouse muscle cells on the bone actions of muscle cell-derived extracellular vesicless.
Takafuji Y, Tatsumi K, Kawao N, Okada K, Muratani M, Kaji H
PLoS One. 2021; 16(5):e0250741.
PMID: 33961664
PMC: 8104413.
DOI: 10.1371/journal.pone.0250741.
The Risks of miRNA Therapeutics: In a Drug Target Perspective.
Zhang S, Cheng Z, Wang Y, Han T
Drug Des Devel Ther. 2021; 15:721-733.
PMID: 33654378
PMC: 7910153.
DOI: 10.2147/DDDT.S288859.